help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reindel, J. F.
Right arrow Articles by Roth, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reindel, J. F.
Right arrow Articles by Roth, R. A.

American Journal of Pathology, Vol 138, 707-719, Copyright © 1991 by American Society for Investigative Pathology


REGULAR ARTICLES

The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells

JF Reindel and RA Roth
Department of Pathology, Michigan State University, East Lansing 48824.

Monocrotaline pyrrole (MCTP), a reactive electrophile, induces delayed and progressive pulmonary edema, vascular remodeling, and pulmonary hypertension after a single intravenous administration to rats. The effects of a single exposure of cultured bovine pulmonary artery endothelial cells (BEC) and bovine pulmonary artery smooth muscle cells (BSMC) to MCTP were examined. Monocrotaline pyrrole caused a dose- dependent, delayed, and progressive cell detachment and release of lactate dehydrogenase activity from monolayers of BECs but not BSMCs. Monolayers of BECs also released increased concentrations of 6-keto- prostaglandin F1 degrees, the stable metabolite of prostacyclin, as the post-treatment interval increased. Progressive and marked endothelial cell hypertrophy occurred after exposure to a nominal concentration of 5 or 50 micrograms/ml of MCTP but not after 0.5 micrograms/ml. Morphologic changes in monolayers of BSMCs were minimal, even up to 2 weeks after exposure. Ultrastructurally the hypertrophic, MCTP-treated BECs had enlarged cell profiles with enlarged nuclei. The nucleoli were prominent, occasionally multiple, and had separation of granular and fibrillar components. Cytoplasmic microtubules and perinuclear intermediate filaments were prominent in some cells, as were the golgi apparatus and endoplasmic reticulum. Degenerative changes were not prominent in cells that remained in the monolayer. Monocrotaline pyrrole inhibited proliferation of both cell types at concentrations (0.5 micrograms/ml) that were not cytotoxic. These findings indicate that MCTP induces direct, dose-dependent injury to cells in culture that is delayed and progressive, and the expression of this injury depends, in part, on the cell type.


This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
P. B. Sehgal and S. Mukhopadhyay
Dysfunctional Intracellular Trafficking in the Pathobiology of Pulmonary Arterial Hypertension
Am. J. Respir. Cell Mol. Biol., July 1, 2007; 37(1): 31 - 37.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Mukhopadhyay, F. Xu, and P. B. Sehgal
Aberrant cytoplasmic sequestration of eNOS in endothelial cells after monocrotaline, hypoxia, and senescence: live-cell caveolar and cytoplasmic NO imaging
Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1373 - H1389.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Mukhopadhyay and P. B. Sehgal
Discordant regulatory changes in monocrotaline-induced megalocytosis of lung arterial endothelial and alveolar epithelial cells
Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1216 - L1226.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Shah, K. Patel, and P. B. Sehgal
Monocrotaline pyrrole-induced endothelial cell megalocytosis involves a Golgi blockade mechanism
Am J Physiol Cell Physiol, April 1, 2005; 288(4): C850 - C862.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Mathew, J. Huang, M. Shah, K. Patel, M. Gewitz, and P. B. Sehgal
Disruption of Endothelial-Cell Caveolin-1{alpha}/Raft Scaffolding During Development of Monocrotaline-Induced Pulmonary Hypertension
Circulation, September 14, 2004; 110(11): 1499 - 1506.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. B. Yee, U. M. Hanumegowda, B. L. Copple, M. Shibuya, P. E. Ganey, and R. A. Roth
Endothelial Cell Injury and Coagulation System Activation during Synergistic Hepatotoxicity from Monocrotaline and Bacterial Lipopolysaccharide Coexposure
Toxicol. Sci., July 1, 2003; 74(1): 203 - 214.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. M. Ito, M. Sato, K. Ushijima, M. Nakai, and K. Ito
Alterations of endothelium and smooth muscle function in monocrotaline-induced pulmonary hypertensive arteries
Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1786 - H1795.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
H. C. Thomas, M. W. Lamé, D. Morin, D. W. Wilson, and H. J. Segall
Prolonged Cell-cycle Arrest Associated with Altered cdc2 Kinase in Monocrotaline Pyrrole-treated Pulmonary Artery Endothelial Cells
Am. J. Respir. Cell Mol. Biol., July 1, 1998; 19(1): 129 - 142.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Society for Investigative Pathology.